What if you could extend your life expectancy by a decade through injecting the blood of young people into your veins? Would you do it?
This avant-gardist “anti-aging therapy” might not appeal to your tastes, but the rich are adhering to it without blinking, and in numbers.
Since money is at stake, a company called Ambrosia has already set up shop in over five major U.S. cities.
Symbolically enough, Ambrosia means “the food of the gods” in Greek and Roman doctrines.
Jesse Karmazin, who is the founder of Ambrosia, has said in an interview for Business Insider that he wished to open the first clinic in New York City by the end of 2018.
He failed this resolution and is now finding solace in the rest of the spots where rich clients can already enjoy a litre or two of young people’s blood.
As I have told you, the price tag is not for everybody, as a litre of blood sells for $8,000, while two litres stand at $12,000. The discount is encouraging clients to purchase the two-litre pack.
The payment can swiftly be done through PayPal, and includes both price options.
It’s no wonder that PayPal stands at the forefront of facilitating payments for this kind of practice, since Peter Thiel (PayPal co-founder) has backed this concept for years with massive funding.
The transfusion technique is called parabiosis, and Thiel says it is a “biological Fountain of Youth – the closest thing science has discovered to an anti-aging panacea.”
Making things even weirder than they are, the scientific definition for parabiosis is “a class of techniques in which two living organisms are joined together surgically and develop single, shared physiological systems, such as shared circulatory systems.”
So, the youth-fountain concept stems from decades of experiments on co-joined organisms that underwent transfusion procedures using blood of their offspring and eventually unveiled ground-breaking results.
As strange as this may sound, you should know that everything is law-compliant, although some may argue (including me) that this practice fails every moral norm.
Donors are 16 to 25-year-old, and those compliant for the procedure need to be at or over 30 years of age.
On the surface, this technology promises to aid people who undergo chemotherapy, elderly folks who are recovering from injuries and, last but not least, reverse ageing.
Research into parabiosis unveiled that, as we age, the approx. 700 proteins in your blood plasma begin to fluctuate, leading to wave changes that affect your tissues and body functions.
If you would substitute the young blood with blood from the elderly and transfuse it to a younger body, it would cause more rapid ageing, just like young blood into an elderly body would lead to rejuvenation of blood cells, therefore acting as an agent that prevents your body from getting old.
With proof of work and an already huge demand, the market for young blood is likely to spike in the following years.
It’s too early to say what implications this will have, but I can imagine how babies and children in developing nations will fall victim to “young blood” traffickers.
Just think about it: if initial tests go according to plan, and for now they are using blood of teens and college students, won’t they further swap to younger people like children or babies?
If the elite becomes obsessed with transfusing young blood, the repercussions are grotesque even to imagine.
For now, this idea is slowly being inoculated in the minds of those who are afraid of dying and are seeking immortality.
So far, no results were released about how this anti-ageing method behaves on human subjects.
Although Ambrosia did their first “clinical trial” on humans in 2017, the results are yet to surface.
This is probably due to the years required to see how effects occur over time.
Even so, the procedure has seen promising results in mice. For some, this is more than enough to adhere to this odd race for immortality.
“In early experiments in mice, Tony Wyss-Coray, a director of the Alzheimer’s research center at Stanford University Medical School who founded a longevity startup focuses on blood plasma called Alkahest, found that swapping old blood plasma for young blood plasma appeared to provide some limited cognitive benefits. The 150-year-old surgical technique he used, parabiosis – involves exchanging the blood of two living organisms.”
Even if the clinical procedure acts as a curtain for what is happening behind the scenes, it won’t change the fact that the elite is using young people’s blood to increase their life expectancy.
It may not sound as gruesome as drinking young’s blood, but the reality is not far from that.
It’s true that there are real beneficial implications of this procedure, but there’s also a dark side appearing so evident, especially in the world we live in today.
What the future holds for us as a species, we are yet to find out. For now, we can only behold at the interesting times we live in.
And, of course, prepare for whatever is to follow.